We intend to focus our search on businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate and, in particular, we will not invest in, or consummate a business combination with, a target business that we determine has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act. Moreover, we expressly disclaim any intent to and will not consummate a business combination with a target business located in China or Hong Kong.

We intend to focus our search for a target business addressing a large market opportunity with a company that is driving its growth in the medicinal cannabis or cannabinoid industry, which are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate. 

We seek to create a “best-in-class” multinational cannabis operator, operating across key markets globally, from cultivation to production and processing, productization, and sales and distribution. We will also target businesses that service or operate adjacent, or ancillary, to the cannabis industry but which are not directly involved in the production, distribution or sale of cannabis.

(Canna-Global Acquisition Corp. said on Nov. 30, 2021, that it had priced its SPAC IPO in line with the terms in its prospectus: 20 million units at $10 each to raise $200 million. The stock and warrants were expected to start trading on Tuesday, Nov. 30, 2021, on the NASDAQ.)